Parkside Financial Bank & Trust - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 211 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$12,556
-20.0%
2730.0%0.00%
-25.0%
Q2 2023$15,690
+97.3%
273
+28.8%
0.00%
+100.0%
Q1 2023$7,951
+50.2%
212
+12.2%
0.00%0.0%
Q4 2022$5,295
+76.5%
189
+61.5%
0.00%
+100.0%
Q3 2022$3,000
-25.0%
1170.0%0.00%0.0%
Q2 2022$4,0000.0%1170.0%0.00%0.0%
Q1 2022$4,000
+33.3%
1170.0%0.00%0.0%
Q4 2021$3,000117
+1362.5%
0.00%
Q2 2021$0
-100.0%
8
-85.2%
0.00%
Q4 2020$1,0000.0%54
+54.3%
0.00%
Q3 2020$1,00035
+59.1%
0.00%
Q2 2020$022
-8.3%
0.00%
Q1 2020$0
-100.0%
24
-38.5%
0.00%
Q3 2019$1,00039
+77.3%
0.00%
Q2 2019$0
-100.0%
22
-26.7%
0.00%
Q1 2019$1,0000.0%30
-25.0%
0.00%
Q4 2018$1,0000.0%400.0%0.00%
Q3 2018$1,00040
+37.9%
0.00%
Q2 2018$0
-100.0%
29
-50.0%
0.00%
Q1 2018$1,0000.0%58
+100.0%
0.00%
Q4 2017$1,0000.0%290.0%0.00%
Q3 2017$1,0000.0%290.0%0.00%
Q2 2017$1,000290.0%0.00%
Q1 2017$029
+26.1%
0.00%
Q4 2016$0230.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders